NCT06588088

Brief Summary

In this study, the investigators are trying to find out of the effect of nighttime eating on metabolism, cardiorenal, hormonal and circadian rhythm, and a study was conducted to examine the effects of diseases that are quite common in internal medicine practice, such as type 2 diabetes mellitus, chronic kidney disease, hypertension, metabolic syndrome and sleep disorders.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
16

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2022

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2023

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

February 16, 2024

Completed
7 months until next milestone

First Posted

Study publicly available on registry

September 19, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2024

Completed
Last Updated

August 26, 2025

Status Verified

August 1, 2025

Enrollment Period

1.6 years

First QC Date

February 16, 2024

Last Update Submit

August 25, 2025

Conditions

Keywords

Night Eating SyndromeNutritionMetabolic Syndrome

Outcome Measures

Primary Outcomes (11)

  • Change of the concentration albuminuria in the Nighttime Eating Period

    More than 20% increase during night feeding period

    1 week

  • Change of the concentration of serum melatonin levels in the Nighttime Eating Period

    More than 50% increase during night feeding period

    1 week

  • Change of the concentration of serum leptin levels in the Nighttime Eating Period

    More than 50% increase during night feeding period

    1 week

  • Change of the Concentration of serum ghrelin Levels in the Nighttime Eating Period

    More than 50% increase during night feeding period

    1 week

  • Change of the concentration of serum total cholesterol, low-density lipoprotein cholesterol, high density lipoprotein cholesterol and triglyceride levels in the Nighttime Eating Period

    More than 20% increase during night feeding period

    1 week

  • Change of Concentration of serum glucose in the Nighttime Eating Period

    More than 10% increase during night feeding period

    1 week

  • Change of Concentration of serum insulin in the Nighttime Eating Period

    More than 10% increase during night feeding period

    1 week

  • Change of concentration of serum Cortisol Level in the Nighttime Eating Period

    More than 50% increase during night feeding period

    1 week

  • Change of concentration of serum Fibroblast Growth Factor 21 Level in the Nighttime Eating Period

    More than 10% increase during night feeding period

    1 week

  • Change of the concentration of serum Cytokeratin 18 level in the Nighttime Eating Period

    More than 10% increase during night feeding period

    1 week

  • Change of value of Apnea Hypopnea Index in the Nighttime Eating Period

    The Apnea-Hypopnea Index (AHI) is an index used to indicate the severity of sleep apnea. It is represented by the number of apnea and hypopnea events per hour of sleep. Apneas (pauses in breathing) must last for at least 10 seconds and be associated with a decrease in blood oxygenation to be considered. Combining AHI and oxygen desaturation gives an overall sleep apnea severity score that evaluates both the number of sleep breathing disruptions and the degree of oxygen desaturation (low oxygen level in the blood) during said disruptions. The AHI is calculated by dividing the number of apnea events by the number of hours of sleep. The AHI values for adults are categorized as: Normal: AHI\<5 Mild sleep apnea: 5≤AHI\<15 Moderate sleep apnea: 15≤AHI\<30 Severe sleep apnea: AHI≥30More than 10% increase during night feeding period

    1 week

Study Arms (2)

Early eaters

PLACEBO COMPARATOR

The diet of these healthy volunteers was such that no calories were consumed after 19.30 in the evening in the first week of the study.

Other: Dietary

Night time Eaters

ACTIVE COMPARATOR

The diet of the same healthy volunteers was 25% of the daily calorie need calculated according to the Harris - Benedict formula was taken, taking into account the night time eating syndrome (NES) criteria, after 20.30 in the evening.

Other: Dietary

Interventions

DietaryOTHER

The diet of these healthy volunteers was such that no calories were consumed after 19.30 in the evening in the first week, and in the second week, 25% of the daily calorie need calculated according to the Harris - Benedict formula was taken, taking into account the nighttime eating syndrome (NES) criteria, after 20.30 in the evening.

Early eatersNight time Eaters

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Being between the ages of 18-65
  • Being willing to adapt to the desired feeding time and calories
  • Body mass index (BMI) is between 18-30
  • Not having any systemic disease, not using chronic medication

You may not qualify if:

  • \<18, \>65 years old
  • Failure to comply with the regulated nutrition program
  • BMI between \<18 and \>30
  • Presence of systemic disease: E.g. Diabetes Mellitus, Chronic Kidney Disease, Coronary Artery Disease, Hypertension etc.
  • Inability to have polygraphy
  • Chronic drug use

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Koc University Hospital

Istanbul, 34010, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Night Eating SyndromeMetabolic SyndromeCardio-Renal SyndromeSleep Wake Disorders

Interventions

Diet

Condition Hierarchy (Ancestors)

Feeding and Eating DisordersMental DisordersInsulin ResistanceHyperinsulinismGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesRenal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesHeart FailureHeart DiseasesCardiovascular DiseasesNervous System DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Nutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological Phenomena

Study Officials

  • Mehmet Kanbay, Medical Doctor

    Koc University, School Of Medicine

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
SINGLE GROUP
Model Details: Nutritional study with a single-arm cross-over design
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Medical Doctor, Resident in Internal Medicine

Study Record Dates

First Submitted

February 16, 2024

First Posted

September 19, 2024

Study Start

May 1, 2022

Primary Completion

December 1, 2023

Study Completion

December 1, 2024

Last Updated

August 26, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share

Locations